Search for: "PFIZER, A Corporation"
Results 1 - 20
of 817
Sorted by Relevance
|
Sort by Date
4 Sep 2009, 7:34 am
Guess how much it will cost Pfizer to not comply fully with this corporate integrity agreement the U.S. [read post]
9 Nov 2009, 6:20 pm
The Pfizer Corporation has announced that it will close down its headquarters in New London, Connecticut. [read post]
22 Nov 2015, 9:11 pm
” The post WashU Expert: Pfizer deal marks the end of U.S. ability to stop corporate tax inversion appeared first on The Source. [read post]
6 Apr 2016, 7:37 pm
The merger, unveiled in November 2015, would have allowed Pfizer to reduce its U.S. corporate tax rate by adoptingThe post New Inversion Rules Stop Pfizer’s Merger With Allergan appeared first on Legal Reader. [read post]
23 Nov 2015, 12:00 am
The Pfizer agreement comes just four days after the administration of President Barack Obama enacted fresh restrictions on corporate tax inversions — reincorporating overseas in a country where the corporate tax rate is lower. [read post]
1 Dec 2021, 6:55 pm
The Office of the Ombuds at Pfizer is celebrating ten years of service to the American multinational pharmaceutical and biotechnology corporation. [read post]
31 Jan 2017, 6:42 am
NCPPR said that boycotts of corporations that advertise on certain news networks have been organized and expose those corporations to risks. [read post]
7 Apr 2005, 4:04 am
[JURIST] Leading Thursday's corporations and securities law news, Pfizer Inc. [read post]
16 Feb 2011, 1:37 pm
Pfizer traces its corporate origins to the neighborhood, having commenced its operations there in 1849. [read post]
20 Apr 2018, 7:06 am
The Pfizer Ombuds team will be attending the IOA annual conference. [read post]
10 Sep 2009, 8:19 am
Our sibling publication, Corporate Counsel, takes a look at the corporate integrity agreement Pfizer signed with federal officials after its $2.3 billion settlement last week. [read post]
28 Apr 2008, 3:26 pm
[JURIST] US pharmaceutical giant Pfizer [corporate website] resumed settlement negotiations with the Nigerian state of Kano for allegedly illegal clinical trials conducted by the drug company, Kano state Justice Commissioner Aliyu Umar said Monday. [read post]
26 Jul 2007, 9:58 am
[JURIST] Nigerian Judge Anwuri Shekere Wednesday suspended court proceedings in the criminal case against pharmaceutical giant Pfizer [corporate website] until October 29, granting a request by prosecutors for more time to prepare. [read post]
3 Apr 2009, 8:09 am
[JURIST] Drug maker Pfizer [corporate website] reached a settlement Friday with the Nigerian state of Kano in a lawsuit over allegedly illegal clinical trials the company conducted in Nigeria in 1996. [read post]
27 Oct 2008, 4:38 pm
[JURIST] Officials from Nigeria and from US pharmaceutical company Pfizer [corporate website] said Monday that they hope to reach a settlement agreement by the end of next month over allegedly illegal clinical trials conducted in Nigeria by the drug company in 1996. [read post]
28 Jul 2009, 2:25 am
[JURIST] Drug maker Pfizer [corporate website] finalized a settlement Monday with the Nigerian state of Kano in a lawsuit over allegedly illegal clinical trials the company conducted in Nigeria in 1996. [read post]
29 Mar 2010, 9:08 am
Big Corporations not acting right, happens all the time: Pfizer Hit With $141 Million RICO Penalty Over Neurontin Promotion: Link To ArticlePRATER,DUNCAN&CRAIG: 770-253-7778: Trial Lawyers For Justice [read post]
10 Apr 2016, 8:20 am
After relatively cautious regulatory tightening on corporate inversions failed to deter a plan by Pfizer to embrace foreign domicile, the Obama administration came out with drastic new guidance that will keep accountants and lawyers busy for years with new disputes and uncertainties. [read post]
15 Dec 2015, 3:05 am
Pfizer, which is based in New York, will move overseas by merging with Allergan, based in Ireland, in a maneuver known as a corporate... [read post]
11 Jun 2021, 12:32 pm
He discusses his views on the value of a role for restorative justice in dispute resolution in corporate contexts, and provides advice for young practitioners looking to go in-house. [read post]
